Page last updated: 2024-10-30

kynurenic acid and Multiple Sclerosis, Chronic Progressive

kynurenic acid has been researched along with Multiple Sclerosis, Chronic Progressive in 1 studies

Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.

Multiple Sclerosis, Chronic Progressive: A form of multiple sclerosis characterized by a progressive deterioration in neurologic function which is in contrast to the more typical relapsing remitting form. If the clinical course is free of distinct remissions, it is referred to as primary progressive multiple sclerosis. When the progressive decline is punctuated by acute exacerbations, it is referred to as progressive relapsing multiple sclerosis. The term secondary progressive multiple sclerosis is used when relapsing remitting multiple sclerosis evolves into the chronic progressive form. (From Ann Neurol 1994;36 Suppl:S73-S79; Adams et al., Principles of Neurology, 6th ed, pp903-914)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rejdak, K1
Bartosik-Psujek, H1
Dobosz, B1
Kocki, T1
Grieb, P1
Giovannoni, G1
Turski, WA1
Stelmasiak, Z1

Other Studies

1 other study available for kynurenic acid and Multiple Sclerosis, Chronic Progressive

ArticleYear
Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients.
    Neuroscience letters, 2002, Oct-04, Volume: 331, Issue:1

    Topics: Adult; Female; Humans; Kynurenic Acid; Male; Multiple Sclerosis, Chronic Progressive; Multiple Scler

2002